Comprehensive Approach to Infant RSV Protection Quality and Innovation Collective (QuIC)
AMGA’s new Comprehensive Approach to Infant RSV Protection Quality and Innovation Collective (QuIC) is a three-phase national quality improvement initiative, designed to help healthcare organizations develop and implement effective strategies to improve infant RSV immunization rates and close critical protection gaps across medical groups and integrated delivery systems
The Infant RSV Protection QuIC utilizes interactive workshops with quality improvement tools and qualitative methodology to engage AMGA member organizations in thoughtful discussions to collect insights and share best practices on creating and implementing successful RSV immunization initiatives.
Participating organizations will focus on five key areas:
- Closing the Protection Gap — Addressing immunization gaps for infants eligible for RSV protection, including high-risk infants requiring prophylaxis during their second RSV season
- Seamless Care Journey — Improving care transitions between hospital and ambulatory settings and addressing missed opportunities across the care continuum
- Trust-Based Communication — Leveraging trusted provider relationships to address vaccine hesitancy and developing culturally responsive patient education strategies
- Technology Enablement — Supporting EHR integration, mother-infant-linking solutions, and patient identification and outreach systems
- Health Equity — Ensuring access and education for underserved communities and addressing disparities in RSV protection rates
The Infant RSV Protection QuIC includes a virtual discussion forum, a two-day in-person meeting, and a two-day virtual meeting.
Comprehensive Approach to Infant RSV Protection QuIC Advisory Committee
- Uzma Shah, MD, FAAP, FAASLD
System Chair of Pediatrics, Medical Director, Pediatric Service Line, Henry Ford Health - Shalini Sethi, MD
Department of Pediatrics, Senior Staff Pediatrician, Division Head Beck Rd, Ford, Taylor, Henry Ford Health - Deb Carter, MD, CPE, FAAP
Senior Medical Director, LVPG Quality Executive Vice Chair, Department of Pediatrics, Clinical Assistant Professor, USF Morsani College of Medicine, Adjunct Clinical Assistant Professor of Pediatrics, Thomas Jefferson University Lehigh Valley Reilly Children’s Hospital - Andrea Polkinghorn, BSN, RN
Lead Immunization Strategist, Sanford Health - Johnathan Domachowske, MD
Medical Director, RSV Sanofi Vaccines
Listen: Virtual Discussion Forum
July 8, 2026
Virtual Discussion Forum:
-
Engage in a virtual discussion forum moderated by a national advisor.
Share: Two-Day In-Person Meeting
November 17–19, 2026
In-Person Meeting:
- Participating organizations will share in educational sessions and interactive activities, collaborating with one another in a structured learning environment.
Implementation:
- Discuss barriers and plans for implementation of tailored interventions. HCOs will share successes and challenges with their tailored intervention implementation.
Create: Two-Day Virtual Meeting
July 14 & 15, 2027
Virtual Meeting:
- Participating organizations will engage in interactive learning with a qualitative focus, breakout rooms, general session. Participants will share successes and challenges with their infant RSV protection program development and enhancement.
For more information about the Infant Protection QuIC, please contact Senait Temesgen at stemesgen@amga.org
The Quality and Innovation Collective (QuIC) Comprehensive Approach to Infant RSV Protection is sponsored by Sanofi.
